@CNN Even though it does not help? 🤔
RT @lonaeva: Sinon on va finir par douter de votre impartialité pour rester poly! Pour vous aider je vous joint un petit article gratuitem…
Sinon on va finir par douter de votre impartialité pour rester poly! Pour vous aider je vous joint un petit article gratuitement histoire juste d'équilibrer l'information et je peut en publier un tous les jours gratuitement bien sur! https://t.co/Kgz0mDlC
RT @Nat_anest: Первые два исследования по Ремдесивиру https://t.co/qKzHyeUnpr
RT @TheLancet: NEW Research—First randomised trial of #remdesivir for hospitalised patients who are critically ill with #COVID19 suggests a…
RT @TheLancet: NEW Research—First randomised trial of #remdesivir for hospitalised patients who are critically ill with #COVID19 suggests a…
There have been 4 trials of Remdesivir so far.(Two predominantly in US/Two outside) First was Wuhan trial(published Mid April) which was cut short due to lack of cases ,which showed no mortality benefit with Remdesivir and a trend towards faster recovery.
RT @Nat_anest: Здесь я делал целый тред по первому исследованию по Ремдессивиру: результат - работает на уровне плацебо: * На летальность…
RT @Nat_anest: Здесь я делал целый тред по первому исследованию по Ремдессивиру: результат - работает на уровне плацебо: * На летальность…
RT @Nat_anest: Здесь я делал целый тред по первому исследованию по Ремдессивиру: результат - работает на уровне плацебо: * На летальность…
RT @Nat_anest: Здесь я делал целый тред по первому исследованию по Ремдессивиру: результат - работает на уровне плацебо: * На летальность…
RT @Nat_anest: Здесь я делал целый тред по первому исследованию по Ремдессивиру: результат - работает на уровне плацебо: * На летальность…
Здесь я делал целый тред по первому исследованию по Ремдессивиру: результат - работает на уровне плацебо: * На летальность не влиял * На сроки выздоровления не влиял * Размножение вируса не замедлял Весь тред здесь, почитайте.https://t.co/qKzHyeUnpr ht
RT @zchagla: 2) April 29 - A group in Wuhan releases one of the first COVID clinical trials - on remdesivir. Small numbers but no real ben…
RT @zchagla: 2) April 29 - A group in Wuhan releases one of the first COVID clinical trials - on remdesivir. Small numbers but no real ben…
2) April 29 - A group in Wuhan releases one of the first COVID clinical trials - on remdesivir. Small numbers but no real benefit (? reduction in time to clinical improvement) - couldn't power study appropriately given improvement in situation in Wuhan h
RT @EmilioAlegre1: OJO: que subgrupo del ACTT-1 con ⬇️ mortalidad en O2 sin alto flujo no sea nada fiable (inconsistente), no descarta la h…
OJO: que subgrupo del ACTT-1 con ⬇️ mortalidad en O2 sin alto flujo no sea nada fiable (inconsistente), no descarta la hipótesis. ¿Cómo investigarlo? 🔝: ECA en ese grupo Mientras: metaanálisis de subgrupos incluyendo SOLIDARITY (fácil). Otro: observacional
This is Deja vu all over again after two early studies showed conflicting results in Lancet (158 patiens) and in NEJM (538 patients). https://t.co/S88aM30WBF https://t.co/c0UTMxQjri
4 de 5. El análisis en pacientes con oxígeno no de alto flujo no fue preespecificado, lo que resta fiabilidad. El resultado aparentement positivo de mortalidad es incoherente con el ECA de Wang et al., que no muestra beneficio en ese tipo de pacientes. htt
10-15-2020: Gilead comments on the 11,266-participant SOLIDARITY trial, in which remdesivir failed to reduce deaths or hospital stays: https://t.co/DAQHZoyDsD https://t.co/IUyTSfhF2o https://t.co/ZEMmihAgLz https://t.co/YtrFRh2FbH https://t.co/f3He7UUFNx
@Cdanslair Tiens Djillali fait la promo du remdesivir qui ne soigne rien et peut avoir des effets secondaires Tres dangereux pour qui roule-t-il ? https://t.co/Kgz0mDlC8O
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial - The Lancet https://t.co/mdCwsybq92
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
@DrHazan @MarcelaSaebL No rolo nada buen hombre, jajaja pero si se de qué artículo se refiere https://t.co/hTEdf0tYiP
@jeanvige En 2005 les #Francais avait 1000 fois raison https://t.co/Kgz0mDlC8O https://t.co/tuCjrZyR8W
RT @bezazlen: Utvrđeno da remdesivir čini da se COVID-19 teže preleži, da ima mnogo više komplikacija i smrtnih slučajeva engo kod ljudi ko…
Utvrđeno da remdesivir čini da se COVID-19 teže preleži, da ima mnogo više komplikacija i smrtnih slučajeva engo kod ljudi koji nisu primali nikakve lekove. Tako da nije čudo što ga je Srbija kupila umesto efikasnog HCQ. https://t.co/M5aBARsGSF
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
#Remdesivir Remdesivir (also GS-5734) is a monophosphoramidate prodrug of an adenosine analogue that has a broad antiviral spectrum https://t.co/P2HUYxBwvX
@iamcuriousblue The best we can say at this point is that remdesivir provides some benefit for hospitalized patients: https://t.co/yfl4hFOKHS
Die mit Remdesivir behandelte Gruppe - "erholte sich etwas schneller, gleichwohl war der Effekt nicht signifikant, bei gleicher Mortalität"/ of waarom die Donald dexamethason nodig heeft en ook nog uitflipt - https://t.co/4FDFqglDau
@KathyKittyQueen @Olivianuzzi Random thing that makes you go 'Huh?' in one of the studies out of China on Remdesivir participants (both sexes) of childbearing age had to agree to use contraception for period of trial & up to 7 days after last dose http
@weldeiry E.g. Fig 3 here: https://t.co/KWHqcNqr1e https://t.co/fdupXmGtRg
RT @raoult_didier: Two trials focused on remdesivir delivered their findings: one published in the Lancet, that concluded to an absence of…
The Lancet : Our trial found that intravenous remdesivir did not significantly improve the time to clinical improvement, mortality, or time to clearance of virus in patients with serious COVID-19 compared with placebo. https://t.co/vLhrwP9LcJ
RT @VivekSubbiah: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial @TheLancet h…
RT @VivekSubbiah: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial @TheLancet h…
RT @VivekSubbiah: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial @TheLancet h…
RT @raoult_didier: Deux études sur le remdesivir ont apporté leurs résultats : une publiée dans le Lancet, qui conclut à la non-efficacité…
@RTerriers2 @HB04920973 @cosmotopper6 Adverse events were reported in 102 (66%) of 155 remdesivir recipients versus 50 (64%) of 78 placebo recipients. The Remdesivir was stopped early because of adverse events in 18 (12%) patients versus four (5%) patients
@MerlG_Official @SHN006 @BostonGlobe Reports of "feeling better" should not be enough to experiment on President of the United States of America! More adverse effects have been shown than not. https://t.co/a7JHxMMZHf
RT @VivekSubbiah: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial @TheLancet h…
While I wish @realDonaldTrump a full and speedy recovery, I am a bit puzzled: why is MSM referring to Remdesivir as a new or experimental drug? https://t.co/Ef4erbhYmE Is Dr Anthony Fauci linked in any way shape or form to the drugs production? I hope for
RT @VivekSubbiah: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial @TheLancet h…
RT @VivekSubbiah: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial @TheLancet h…
RT @VivekSubbiah: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial @TheLancet h…
In this study of adults admitted to hospital for severe COVID-19 Remdesivir did not show statistically significant clinical benefits. However, the reduction in time to clinical improvement requires confirmation in larger studies. https://t.co/6iizKMPeJT
RT @VivekSubbiah: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial @TheLancet h…
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial @TheLancet https://t.co/fx8t0R0boe
Remdesivir in adults w/ severe #COVID19: a randomised, double-blind, placebo-controlled, multicentre trial [Apr 29, 2020] Wang et al. @TheLancet https://t.co/En1E8CFrVZ #CCC19 #2019nCoV #COVID19ClinicalTrials n=237 Lancet Discussion Thread: https://t.co/
#Remdesivir was not associated with statistically significant clinical benefits. President should get a second and third opinions. @realDonaldTrump @VP @DonaldJTrumpJr @PressSec @CBS_Herridge https://t.co/cutGsCLyDi https://t.co/WGj9Q4Rs8J
@RossCameron4 @POTUS @FLOTUS @RossCameron4 not every Remdesivir trial shows the results produced by funny little doctor types in the US. https://t.co/bl3GHALLSd
RT @rustoleumlove: @JasonLeopold while an NEJM study said the drug benefits some ppl, another trial (the Lancet) said no statistically sig…
RT @rustoleumlove: @JasonLeopold while an NEJM study said the drug benefits some ppl, another trial (the Lancet) said no statistically sig…
RT @puppy_chow1: @LukeMor19529310 https://t.co/DQubK6f472. Yup, I concur. So far, no mortality data is available yet.
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial - The Lancet. What Trump is being given https://t.co/3Rz2xSimOi
@JasonLeopold while an NEJM study said the drug benefits some ppl, another trial (the Lancet) said no statistically significant benefit over placebo. halted bc of adverse events i'd think if it was great, we'd hear more about it. https://t.co/jcHZLepoXP
@LukeMor19529310 https://t.co/DQubK6f472. Yup, I concur. So far, no mortality data is available yet.
RT @KFSHRC_Research: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial “#Remdes…
RT @MarkHoofnagle: So how could inhibiting RDRP after the fact help? The answer is, it probably doesnt. It certainly didn’t in this trial…
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
@DegrafH @boutaour @IHU_Marseille @raoult_didier Tout comme les #Vendus pro poison remdesivir et dérivés ! https://t.co/Kgz0mDlC8O
D’autant plus bête qu’on le sait depuis avril .. https://t.co/5FjwLLphTx https://t.co/8iosUjcPiu
@LionsGregory On ne l'as pas beaucoup entendu sur le #Remdesivir ? Serait-ce un signe? https://t.co/Kgz0mDlC8O
RT @CorinneReverbel: Ne pas oublier la publication publiée par erreur sur le site de l'OMS et vite supprimée qui montrait que le #Remdesivi…
RT @lonaeva: @biobiobiobior Expert à L'#Oms 🤣 et magouilleurs aussi ? https://t.co/Kgz0mDDd0m
RT @lonaeva: @biobiobiobior Expert à L'#Oms 🤣 et magouilleurs aussi ? https://t.co/Kgz0mDDd0m
@biobiobiobior Expert à L'#Oms 🤣 et magouilleurs aussi ? https://t.co/Kgz0mDDd0m
@gregmercie @palindromica https://t.co/wu0tRnDKeF. New England Journal of medicine, The Lancet about REmdesivir. https://t.co/hTzVWk13BF. Read the científic medical articles ..
RT @juanjromero: @jaimeraulmolina @ChrisjamesD @lord_kir17 @TReporta Y el remdesivir si tiene: 1) fama de ser impulsado sin evidencia 2) Ev…
@jaimeraulmolina @ChrisjamesD @lord_kir17 @TReporta Y el remdesivir si tiene: 1) fama de ser impulsado sin evidencia 2) Evidencia de efectos negativos https://t.co/vCAL6jOi3f https://t.co/h71WalVJPN
@andrecriso @ricpuglisi Letteratura tipo questa? https://t.co/204Ey607qe Oppure questa? https://t.co/2ojoXvyPJI
@TF1LeJT Allo #Tf1F1LEJT vous avez dit que l'#OMS déconseille la chloroquine mais vous svez oublie de dire qu'ils roulent pour le #Poison #Remdesivir et ses detives pourquoi? https://t.co/Kgz0mDlC8O
RT @LukeMor19529310: 7/ Then we found out that Fauci rushed his announcement, because someone released another study to the Lancet, showing…
Wang (2020) RCT of REMD vs PLACEBO with SARS-CoV-2 & ≤94% / FIO ≤300mmHg. 10day median time to enrollment; Endpoint - 2point improvement on a 6-point ordinal scale of clinical status (from 1=discharged to 6=death) or discharged alive from hospital http
RT @LukeMor19529310: 7/ Then we found out that Fauci rushed his announcement, because someone released another study to the Lancet, showing…
RT @LukeMor19529310: 7/ Then we found out that Fauci rushed his announcement, because someone released another study to the Lancet, showing…
RT @LukeMor19529310: 7/ Then we found out that Fauci rushed his announcement, because someone released another study to the Lancet, showing…
RT @LukeMor19529310: 7/ Then we found out that Fauci rushed his announcement, because someone released another study to the Lancet, showing…